Medtronic Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Year Ending	TTM	Apr 26, 2024	Apr 28, 2023	Apr 29, 2022	Apr 30, 2021	Apr 24, 2020	2019 - 1995
Net Income	3,676	3,676	3,758	5,039	3,606	4,789	Upgrade
Depreciation & Amortization	2,647	2,647	2,697	2,707	2,702	2,663	Upgrade
Share-Based Compensation	393	393	355	359	344	297	Upgrade
Other Operating Activities	71	71	-771	-759	-412	-515	Upgrade
Operating Cash Flow	6,787	6,787	6,039	7,346	6,240	7,234	Upgrade
Operating Cash Flow Growth	12.39%	12.39%	-17.79%	17.72%	-13.74%	3.24%	Upgrade
Capital Expenditures	-1,587	-1,587	-1,459	-1,368	-1,355	-1,213	Upgrade
Acquisitions	-211	-211	-1,867	-91	-994	-488	Upgrade
Change in Investments	-307	-307	-171	-190	-463	-1,465	Upgrade
Other Investing Activities	-261	-261	4	-10	-54	-37	Upgrade
Investing Cash Flow	-2,366	-2,366	-3,493	-1,659	-2,866	-3,203	Upgrade
Dividends Paid	-3,666	-3,666	-3,616	-3,383	-3,120	-2,894	Upgrade
Share Issuance / Repurchase	-1,854	-1,854	-337	-2,115	-178	-664	Upgrade
Debt Issued / Paid	1,073	1,073	-598	-1	-570	-559	Upgrade
Other Financing Activities	-3	-3	-409	163	-268	-81	Upgrade
Financing Cash Flow	-4,450	-4,450	-4,960	-5,336	-4,136	-4,198	Upgrade
Exchange Rate Effect	-230	-230	243	-231	215	-86	Upgrade
Net Cash Flow	-259	-259	-2,171	121	-547	-253	Upgrade
Free Cash Flow	5,200	5,200	4,580	5,978	4,885	6,021	Upgrade
Free Cash Flow Growth	13.54%	13.54%	-23.39%	22.37%	-18.87%	2.52%	Upgrade
Free Cash Flow Margin	16.07%	16.07%	14.67%	18.87%	16.22%	20.82%	Upgrade
Free Cash Flow Per Share	3.92	3.92	3.44	4.45	3.63	4.49	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).